EcoDrugPlus

Cathepsin K-Like

Ensembl ID : ENSPLAG00000013430
Gene Symbol: LOC106949137
3 Cross references
222 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSPLAG00000013436
Gene Symbol: LOC106949136
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSPLAG00000005408
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPLAG00000018175
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSPLAG00000020734
Gene Symbol: CCR9A
1 Cross references
188 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSPLAG00000015339
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSPLAG00000001723
Gene Symbol: CCKBR
3 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSPLAG00000001190
Gene Symbol: LOC106935258
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSPLAG00000013474
Gene Symbol: LOC106956892
2 Cross references
252 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSPLAG00000014603
Gene Symbol: LOC106956894
2 Cross references
250 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSPLAG00000023200
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPLAG00000010173
Gene Symbol: CHRM3
3 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).